Dosing Weight and Pre-Calculated Dose Aids in the European Resuscitation Council Guidelines 2025 Paediatric Life Support: A Document Analysis, Evidence Review and Reference-Chart Modelling Study
Children · 18.11.2026 · 13 (11) · 1605
DOI: 10.3390/children13111605 ↗Kurz gefasst
Leitlinie in der Zeitschrift Children, online erschienen am 18.11.2026. Verfasst von Adam Jakubowski und 3 weiteren Autor:innen. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Reanimation
Abstract (Originalsprache)
Introduction
The European Resuscitation Council (ERC) Guidelines 2025 Paediatric Life Support prefer ideal body weight (IBW) for hydrophilic drugs and no longer explicitly recommend pre-calculated dose aids.
Objective
To examine what the guidelines state and cite, the evidence, and resulting dose differences.
Methods
An exploratory study combining a document analysis of the ERC paediatric guidelines 2015–2025 and 20 comparator documents; a structured, non-systematic evidence review; and a deterministic calculation, from World Health Organization growth references (2–15 years), of total body weight (TBW) at −2 to +3 standard deviations (SD) of body mass index-for-age relative to IBW.
Results
The IBW statement (explanatory text only) has no reference, method or threshold; recommended estimation methods return TBW. At 2–10 years, TBW-based doses exceeded IBW-based doses by 18–36% at +2 SD and 28–71% at +3 SD (up to 40% and 78% at 11–15 years); at −2 SD they were 14–22% lower. These are differences between intended doses, not administration errors. Our searches identified no pharmacokinetic study of adrenaline in children with obesity, no comparison of dosing scalars and no study showing harm from such differences. Explicit pre-calculated dose advice (2021) gave way, unlisted among the changes, to a system-level recommendation of standardised drug calculations and cognitive aids, which the guideline retains. In two before–after evaluations of one dosing ruler, threefold deviations fell from 22.0% to 2.2% and 9.9%; deviations above 20% did not.
Conclusions
For children with obesity aged 2–10 years, the guideline points to two dosing weights differing by about 20–70%; within the limits of a non-systematic search, we found no pharmacokinetic or outcome data favouring either. Guideline groups may wish to consider referencing or withdrawing the statement, defining any retained IBW method and naming pre-calculated, volume-based dose aids.
Zitieren
APA
Jakubowski, A., Sosiński, D., Ładny, J. R., & Wojewódzka-Żelezniakowicz, M. (2026). Dosing Weight and Pre-Calculated Dose Aids in the European Resuscitation Council Guidelines 2025 Paediatric Life Support: A Document Analysis, Evidence Review and Reference-Chart Modelling Study. Children, 13(11), 1605. https://doi.org/10.3390/children13111605
Vancouver
Jakubowski A, Sosiński D, Ładny JR, Wojewódzka-Żelezniakowicz M. Dosing Weight and Pre-Calculated Dose Aids in the European Resuscitation Council Guidelines 2025 Paediatric Life Support: A Document Analysis, Evidence Review and Reference-Chart Modelling Study. Children. 2026;13(11):1605. doi:10.3390/children13111605
BibTeX
@article{Jakubowski2026,
author = {Jakubowski, Adam and Sosiński, Daniel and Ładny, Jerzy Robert and Wojewódzka-Żelezniakowicz, Marzena},
title = {Dosing Weight and Pre-Calculated Dose Aids in the European Resuscitation Council Guidelines 2025 Paediatric Life Support: A Document Analysis, Evidence Review and Reference-Chart Modelling Study},
journal = {Children},
year = {2026},
volume = {13},
number = {11},
pages = {1605},
doi = {10.3390/children13111605}
}
EUVIMED